FDA Inspection 1097616 — Arcman Pharma Corporation

Arcman Pharma Corporation — FEI 3003724791

The FDA completed an inspection of Arcman Pharma Corporation on July 26, 2019 in Ontario, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 26, 2019
Fiscal Year
2019
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Ontario, CA (United States)

Citations

IDCFRDescription
1585321 CFR 111.73Specifications met - identity, purity, strength, composition
1592721 CFR 111.103Written procedures - quality control operations
1598621 CFR 111.123(b)(2)Quality control - batch, product specifications